Stay updated with breaking news from Tim Oldham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AdAlta Ltd (ASX:1AD) has released new data providing promising evidence for the effective use of AD-214 in treating patients with Idiopathic Pulmonary...
AdAlta Ltd (ASX:1AD) managing director Tim Oldham chats to Proactive’s Elisha Newell ahead of the Peak Asset Management Microcap Conference on Thursday,...
AdAlta Ltd (ASX:1AD) managing director Tim Oldham updates Proactive on the health care stock’s lead AD-214 i-body after it secured ethics approval to extend...
Melbourne, Australia--(Newsfile Corp. - May 30, 2023) - AdAlta Limited (ASX:1AD), the clinical stage drug discovery company developing novel therapeutic products from its i-body platform, today announced
Melbourne, Australia--(Newsfile Corp. - May 30, 2023) - AdAlta Limited (ASX:1AD), the clinical stage drug discovery company developing